Literature DB >> 25608124

Effect of speech therapy and pharmacological treatment in prosody of parkinsonians.

Luciana Lemos de Azevedo1, Irene Soares de Souza2, Patrícia Marques de Oliveira3, Francisco Cardoso4.   

Abstract

OBJECTIVE: Parkinsonian patients usually present speech impairment. The aim of this study was to verify the influence of levodopa and of the adapted Lee Silverman Vocal Treatment® method on prosodic parameters employed by parkinsonian patients.
METHOD: Ten patients with idiopathic Parkinson's disease using levodopa underwent recording of utterances produced in four stages: expressing attitudes of certainty and doubt and declarative and interrogative modalities. The sentences were recorded under the effect of levodopa (on), without the effect of levodopa (off); before and after speech therapy during the on and off periods.
RESULTS: The speech therapy and its association with drug treatment promoted the improvement of prosodic parameters: increase of fundamental frequency measures, reduction of measures of duration and greater intensity.
CONCLUSION: The association of speech therapy to medication treatment is of great value in improving the communication of parkinsonian patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25608124     DOI: 10.1590/0004-282X20140193

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  2 in total

1.  Utilization of rehabilitation therapy services in Parkinson disease in the United States.

Authors:  Michelle E Fullard; Dylan P Thibault; Andrew Hill; Joellyn Fox; Danish E Bhatti; Michelle A Burack; Nabila Dahodwala; Elizabeth Haberfeld; Drew S Kern; Olga S Klepitskava; Enrique Urrea-Mendoza; Phillip Myers; Jay Nutt; Miriam R Rafferty; Jason M Schwalb; Lisa M Shulman; Allison W Willis
Journal:  Neurology       Date:  2017-08-23       Impact factor: 9.910

2.  Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: a pilot randomised controlled trial (PD COMM pilot).

Authors:  Catherine M Sackley; Christina H Smith; Caroline E Rick; Marian C Brady; Natalie Ives; Smitaa Patel; Rebecca Woolley; Francis Dowling; Ramilla Patel; Helen Roberts; Sue Jowett; Keith Wheatley; Debbie Kelly; Gina Sands; Carl E Clarke
Journal:  Pilot Feasibility Stud       Date:  2018-01-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.